Showing results (61-70 of 204) with videos related to
Sort By:
Pageof 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2004
Adjuvant chemotherapy for resected adenocarcinoma of the esophagus, gastro-esophageal junction, and cardia: phase II trial (E8296) of the Eastern Cooperative Oncology GroupMary Armanios, Ronghui Xu, Arlene A Forastiere, et al.Burns : Journal of the International Society for Burn Injuries|June 15, 2026
Comparative efficacy and economic impact of sequential triple therapy versus nano-silver dressings in delayed-presentation low-temperature burns: A retrospective cohort studyShijie Li, Xinghua Sun, Weijing Sun, et al.Oncology (Williston Park, N.Y.)|February 3, 2005
Concurrent RT with 5-FU/epirubicin and cisplatin or irinotecan for locally advanced upper GI adenocarcinomaWeijing Sun, Richard Whittington, Maryann Gallagher, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297Jordan D Berlin, Paul Catalano, James P Thomas, et al.The American Journal of Surgical Pathology|July 29, 2016
Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite InstabilityChangqing Ma, Krishna Patel, Aatur D Singhi, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 3, 2020
Controversies in Rectal Cancer Treatment and ManagementWeijing Sun, Raed Al-Rajabi, Rodrigo O Perez, et al.Investigational New Drugs|January 24, 2017
A phase 1 study of the pharmacokinetics of nucleoside analog trifluridine and thymidine phosphorylase inhibitor tipiracil (components of TAS-102) vs trifluridine aloneJames M Cleary, Lee S Rosen, Kenichiro Yoshida, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2010
Phase II study of sorafenib in combination with docetaxel and cisplatin in the treatment of metastatic or advanced gastric and gastroesophageal junction adenocarcinoma: ECOG 5203Weijing Sun, Mark Powell, Peter J O'Dwyer, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 8, 2023
A novel outpatient regimen in management of fluoropyrimidine-induced cardiotoxicityAnup Kasi, Pramod Gaudel, Manidhar Lekkala, et al.JAMA Network Open|December 16, 2020
Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysisAnup Kasi, Saqib Abbasi, Shivani Handa, et al.Pageof 21